Pages that link to "Q34274795"
Jump to navigation
Jump to search
The following pages link to DNA methylation of RASSF1A, HIN‐1, RAR‐β, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma (Q34274795):
Displaying 50 items.
- Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer (Q26738987) (← links)
- Characterization of DNA Methylation in Circulating Tumor Cells (Q26778427) (← links)
- TWIST1 is expressed in colorectal carcinomas and predicts patient survival (Q28477528) (← links)
- Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions (Q29614512) (← links)
- Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours. (Q30979173) (← links)
- Cytodifferentiation by retinoids, a novel therapeutic option in oncology: rational combinations with other therapeutic agents (Q33279222) (← links)
- Twist expression promotes migration and invasion in hepatocellular carcinoma (Q33483712) (← links)
- Hypermethylation of CDKN2A exon 2 in tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients (Q33556583) (← links)
- Unraveling breast cancer heterogeneity through transcriptomic and epigenomic analysis (Q33570282) (← links)
- Hypermethylated 14-3-3-sigma and ESR1 gene promoters in serum as candidate biomarkers for the diagnosis and treatment efficacy of breast cancer metastasis (Q33582678) (← links)
- RASSF1A promoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNA. (Q33591552) (← links)
- Human mammary cancer progression model recapitulates methylation events associated with breast premalignancy (Q33627196) (← links)
- Array-Based DNA Methylation Profiling for Breast Cancer Subtype Discrimination (Q33689442) (← links)
- Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis. (Q33738694) (← links)
- Epigenome remodelling in breast cancer: insights from an early in vitro model of carcinogenesis (Q33739319) (← links)
- Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy. (Q33796956) (← links)
- Hypermethylation of tumor suppressor genes involved in critical regulatory pathways for developing a blood-based test in breast cancer (Q33808960) (← links)
- Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer (Q33892868) (← links)
- Promoter methylation and the detection of breast cancer (Q33911603) (← links)
- The promoter methylation status and mRNA expression levels of CTCF and SIRT6 in sporadic breast cancer (Q34088277) (← links)
- Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas (Q34170505) (← links)
- An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine (Q34221765) (← links)
- Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases (Q34245828) (← links)
- Relationship between tumor DNA methylation status and patient characteristics in African-American and European-American women with breast cancer (Q34305047) (← links)
- Field cancerization in mammary carcinogenesis - Implications for prevention and treatment of breast cancer (Q34310997) (← links)
- Targeted apc;twist double-mutant mice: a new model of spontaneous osteosarcoma that mimics the human disease (Q34398283) (← links)
- Epigenetic alteration of p16 and retinoic acid receptor beta genes in the development of epithelial ovarian carcinoma (Q34423868) (← links)
- DNA-methylation profiling distinguishes malignant melanomas from benign nevi (Q34775571) (← links)
- Basal-like breast cancer displays distinct patterns of promoter methylation (Q34982503) (← links)
- DNA methylation epigenotypes in breast cancer molecular subtypes (Q34989097) (← links)
- Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors (Q35008011) (← links)
- Methylated genes in breast cancer: associations with clinical and histopathological features in a familial breast cancer cohort (Q35050475) (← links)
- Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer. (Q35082784) (← links)
- Body mass and DNA promoter methylation in breast tumors in the Western New York Exposures and Breast Cancer Study (Q35163939) (← links)
- Aberrant promoter methylation of HIN-1 gene may contribute to the pathogenesis of breast cancer: a meta-analysis (Q35172269) (← links)
- Molecular drivers of lobular carcinoma in situ (Q35676504) (← links)
- Gene promoter hypermethylation in ductal lavage fluid from healthy BRCA gene mutation carriers and mutation-negative controls (Q35749369) (← links)
- Hormone Replacement Therapy, Likely Neither Angel Nor Demon (Q35780539) (← links)
- Promoter Methylation of the Retinoic Acid Receptor Beta2 (RARβ2) Is Associated with Increased Risk of Breast Cancer: A PRISMA Compliant Meta-Analysis (Q35801560) (← links)
- Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence (Q35841605) (← links)
- The mitogen-activated protein kinase phosphatase-1 (MKP-1) gene is a potential methylation biomarker for malignancy of breast cancer (Q36005081) (← links)
- Soy isoflavones have an antiestrogenic effect and alter mammary promoter hypermethylation in healthy premenopausal women (Q36079644) (← links)
- Quantitative evaluation of DNA hypermethylation in malignant and benign breast tissue and fluids (Q36100208) (← links)
- The Silencing of CCND2 by Promoter Aberrant Methylation in Renal Cell Cancer and Analysis of the Correlation between CCND2 Methylation Status and Clinical Features (Q36119674) (← links)
- Biologic characteristics of premalignant breast disease (Q36204798) (← links)
- Correlation between CpG methylation profiles and hormone receptor status in breast cancers (Q36393321) (← links)
- Detection of promoter methylation of tumor suppressor genes in serum DNA of breast cancer cases and benign breast disease controls (Q36402760) (← links)
- Epigenetics as a therapeutic target in breast cancer (Q36449057) (← links)
- DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines (Q36465214) (← links)
- Molecular biomarkers for cancer detection in blood and bodily fluids (Q36627755) (← links)